- Suspected immune thrombocytopenia associated with Crohn's disease2020 | First Faculty of Medicine
- Immune thrombocytopenia of adults - current view on etiopathogenesis, diagnosis and treatment.2012 | First Faculty of Medicine
- Current questions of the therapy for immune thrombocytopenia of adults2016 | First Faculty of Medicine
- New trends in the treatment of immune thrombocytopenia during the COVID-19 pandemic2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Immune thrombocytopenia: guide attending physicians: pathophysiology, diagnosis, therapy2015 | Third Faculty of Medicine
- Current treatment options for immune thrombocytopenia in adults2020 | First Faculty of Medicine
- Recommendations of the Czech Society of Haematology for the diagnosis and treatment of immune thrombocytopenia in adults2023 | Central Library of Charles University
- Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity2015 | Third Faculty of Medicine
- Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia2022 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura2004 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Current views on the pathophysiology, diagnosis and treatment of immune thrombocytopenia in children2021 | Publication without faculty affiliation
- Efficacy of rituximab in primary immune thrombocytopenia: An analysis of adult pretreated patients from everyday hematological practice2012 | Central Library of Charles University, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Immune thrombocytopenia in a patient with essential thrombocythemia after SARS-CoV-2 infection: A case report2023 | Third Faculty of Medicine
- A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice2017 | Third Faculty of Medicine
- Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice2021 | Third Faculty of Medicine
- Rilzabrutinib, an Oral BTK Inhibitor, in Immune Thrombocytopenia2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Immune thrombocytopenia as a complication of acute infectious diseases - case reports2013 | First Faculty of Medicine, Second Faculty of Medicine
- Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam 10%) in patients with immune thrombocytopenia2010 | First Faculty of Medicine
- Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura2004 | Faculty of Medicine in Pilsen
- Frequency of antiglycoprotein antibodies established by the MAIPA method in children with immune thrombocytopenia2000 | Second Faculty of Medicine
- Alemtuzumab in the treatment of multiple sclerosis: a haematologist perspective2017 | Third Faculty of Medicine
- Eltrombopag2015 | First Faculty of Medicine
- Haematopoetic stem cell transplantation for refractory autoimmune cytopenia2004 | Second Faculty of Medicine
- Newborn of mother affected by autoimmune diseasePublication without faculty affiliation
- Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use2015 | First Faculty of Medicine
- Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia2017 | Second Faculty of Medicine
- New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation2013 | Second Faculty of Medicine
- Understanding the positive benefit: risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program2017 | First Faculty of Medicine, Second Faculty of Medicine